List of Major Drug Patent Expirations Happening in 2018
With every year that passes, more and more brand drug patent expirations occur. This year is no different. Some major drugs, like Lyrica, Spiriva, and Symbicort, will all lose some patent protections in 2018, paving the way for generic alternatives and lower prices.
The patents for medications typically last for around 20 years after the initial application date. Patents protection can vary by how the drug is marketed. For example, a drug may lose its patent protection for certain treatments, but may maintain it for a longer period of time, when it relates to other treatments.
Here are the major drug patent expirations for 2018
Generic name: Tiotropium
Patent expiration date: January 30, 2018
Spiriva is a bronchodilator that works by relaxing muscles in the airways and increases air flow to the lungs. It is used to treat bronchospasms in adults with chronic obstructive pulmonary disease (COPD).
Generic name: Hydroxyprogesterone
Patent expiration date: February 3, 2018
Makena is a manmade form of a female hormone called progesterone. It is used to lower the risk of premature birth in women who have already had one premature baby. The drug cannot stop premature labor when it has already begun.
Generic name: Cinacalcet
Patent expiration date: March 8, 2018
Used to treat hyperparathyroidism, Sensipar decreases levels of parathyroid hormone, calcium, and phosphorous in the body. People who are on long-term dialysis for kidney disease are prescribed this medication.
Generic name: Dofetilide
Patent expiration date: October 9, 2018
Tikosyn is a heart rhythm medicine, used to treat abnormal heartbeats. It is called an anti-arrhythmic. The medication is used to keep the heart beating normally in people with certain heart rhythm disorders of the atrium. It is also used in people with atrial fibrillation or atrial flutter.
Generic name: Vardenafil
Patent expiration date: October 31, 2018
A medicine used to treat erectile dysfunction, Levitra relaxes muscles found in the walls of blood vessels and increases blood flow to certain areas of the body. It may also be used for other purposes than this.
Generic name: Budesonide/formoterol
Patent expiration date: Nov. 11, 2018
In people with asthma or chronic obstructive pulmonary diseases, Symbicort is used to prevent bronchospasms. Symbicort contains combinations of budesonide and formoterol. Budesonide is a steroid, used to reduce inflammation in the body, whereas formoterol improves breathing, by relaxing muscles in the airways.
The above list represents some of the more common drug patents that expiring in 2018. Below, we have listed other drug patents that are expiring in 2018.
Other drug patents expiring in 2018
Adipra – Expires June 18, 2018
Astepro – Expires February 20, 2018
Finacea – Expires November 18, 2018
Follistim – Expires January 14, 2018
Fortesta – Expires November 9, 2018
Lexiva – Expires June 24, 2018
Promacta – Expires October 30, 2018
Staxyn – Expires October 31, 2018
Tekturna – Expires July 21, 2018
Tekturna HCT – Expires July 21, 2018
Tyvaso – Expires November 13, 2018
Rx Saver’s Health Information Center is meant for educational purposes and is not intended for medical advice. If you would like to recommend any story ideas, feel free to contact us.